Emmaus Life Sciences, Inc. (EMMA)
OTCMKTS
· Delayed Price · Currency is USD
0.0086
-0.0054 (-38.57%)
Jan 17, 2025, 4:00 PM EST
Emmaus Life Sciences Revenue
Emmaus Life Sciences had revenue of $5.48M in the quarter ending September 30, 2024, with 9.17% growth. This brings the company's revenue in the last twelve months to $20.43M, down -28.22% year-over-year. In the year 2023, Emmaus Life Sciences had annual revenue of $29.60M with 60.94% growth.
Revenue (ttm)
20.43M
Revenue Growth
-28.22%
P/S Ratio
0.03
Revenue / Employee
385.43K
Employees
55
Market Cap
549.24K
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 29.60M | 11.21M | 60.94% |
Dec 31, 2022 | 18.39M | -2.22M | -10.77% |
Dec 31, 2021 | 20.61M | -2.56M | -11.04% |
Dec 31, 2020 | 23.17M | 415.00K | 1.82% |
Dec 31, 2019 | 22.75M | 6.29M | 38.23% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Endo Inc. | 1.79B |
Veradigm | 1.53B |
SS Innovations International | 16.04M |
Elite Pharmaceuticals | 71.17M |
Glass House Brands | 188.29M |
Northwest Biotherapeutics | 1.60M |
BioStem Technologies | 210.49M |
Silence Therapeutics | 21.77M |
Emmaus Life Sciences News
- 2 months ago - Emmaus Life Sciences Reports Improved Quarterly Financial Results - PRNewsWire
- 4 months ago - Emmaus Life Sciences Reports Quarterly Financial Results - PRNewsWire
- 6 months ago - Emmaus Life Sciences Announces Willis C. Lee as Chief Executive Officer - PRNewsWire
- 6 months ago - Emmaus Life Sciences Announces Outcome of FDA Inspection of Postmarketing Adverse Drug Experience Compliance Program - PRNewsWire
- 7 months ago - Emmaus Life Sciences Reports 2023 Financial Results - PRNewsWire
- 10 months ago - Emmaus Life Sciences Reports Delayed Filing of Annual Report - PRNewsWire
- 1 year ago - Emmaus Life Sciences Receives Marketing Authorization for Puerto Rico - PRNewsWire
- 1 year ago - Emmaus Life Sciences Reports Q3 2023 Financial Results - PRNewsWire